Chiang, K., Yeh, T., Wu, R., Pang, J. S., Cheng, C., Wang, S., . . . Yeh, C. (2016). Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker. Sci Rep.

Chiang, Kun-Chun, Ta-Sen Yeh, Ren-Chin Wu, Jong-Hwei S. Pang, Chi-Tung Cheng, Shang-Yu Wang, Horng-Heng Juang, and Chun-Nan Yeh. "Lipocalin 2 (LCN2) Is a Promising Target for Cholangiocarcinoma Treatment and Bile LCN2 Level Is a Potential Cholangiocarcinoma Diagnostic Marker." Sci Rep 2016.

Chiang, Kun-Chun, et al. "Lipocalin 2 (LCN2) Is a Promising Target for Cholangiocarcinoma Treatment and Bile LCN2 Level Is a Potential Cholangiocarcinoma Diagnostic Marker." Sci Rep 2016.